Document Detail


Long-term comparative analysis from an all-comer cohort of coronary patients treated using first- and second-generation drug-eluting stents.
MedLine Citation:
PMID:  25091097     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
AIMS: Second-generation drug eluting stent (DES) implantation gradually replaced the first-generation DES in clinical practice. Whether the new DESs in use differ from one another, in terms of clinical outcomes, is still not known. We explored potential differences among DESs.
METHODS AND RESULTS: We followed 9584 consecutive patients undergoing percutaneous coronary intervention at our institution (2004-2012; mean follow-up, 2.8 years). Patients treated with bare-metal stent (BMS; n = 5599; 58.4%) were compared to 3985 DES counterparts (41.5%). The sirolimus-eluting stent (SES) served as the prototype for comparison to other DES types, using propensity matching. The primary outcome was a composite endpoint of total mortality, myocardial infarction, and clinically driven target vessel revascularization or coronary artery bypass graft. At 3 years, the composite endpoint was significantly lower in the DES vs BMS group (17.9% vs 25.3%; P<.001). Comparisons between SES and each of the five other stent types yielded no significant differences for the primary composite endpoint: SES vs paclitaxel-eluting stent (n = 350 pairs; 18.1% vs 17.7%; P=.70); vs zotarolimus-eluting stent (n = 474 pairs; 21.8% vs 23.2%; P=.35); vs Resolute zotarolimus-eluting stent (n = 434 pairs; 16.9% vs 11.7%; P=.70); vs everolimus-eluting stent (n = 824 pairs; 14.2% vs 14.1%; P=.60); and vs biolimus-eluting stent (n = 117 pairs 13.7% vs 13.4%; P=.60).
CONCLUSIONS: Cardiac prognosis did not differ between sirolimus and other DES types. The use of DES was associated with better clinical outcomes compared to BMS.
Authors:
Pablo Codner; Tamir Bental; Abid Assali; Hana Vaknin-Assa; Eli Lev; Ran Kornowski
Related Documents :
24952867 - Preprocedural statin use in patients undergoing percutaneous coronary intervention.
24647117 - Prospective study of the association between dispositional optimism and incident heart ...
24065447 - Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting...
24903987 - Is right ventricular mid-septal pacing superior to apical pacing in patients with high ...
21091607 - Determinants of right ventricular failure in patients admitted with acute left heart fa...
10436127 - Therapeutic benefit. aspirin revisited in light of the introduction of clopidogrel.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  26     ISSN:  1557-2501     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-08-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  378-84     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Guidewire-Induced Coronary Artery Perforation and Tamponade During PCI: In-Hospital Outcomes and Imp...
Next Document:  Preliminary Experience in the Use of CERA Occluders for Closure of Different Intracardiac and Extrac...